首页> 外文期刊>The journal of immunology >Loss of Direct and Maintenance of Indirect Alloresponses in Renal Allograft Recipients: Implications for the Pathogenesis of Chronic Allograft Nephropathy
【24h】

Loss of Direct and Maintenance of Indirect Alloresponses in Renal Allograft Recipients: Implications for the Pathogenesis of Chronic Allograft Nephropathy

机译:肾脏同种异体移植接受者的直接损失和间接同种异体反应的维持:对慢性同种异体移植肾病发病机制的影响

获取原文
           

摘要

Chronic allograft nephropathy (CAN) is the principal cause of late renal allograft failure. This complex process is multifactorial in origin, and there is good evidence for immune-mediated effects. The immune contribution to this process is directed by CD4+ T cells, which can be activated by either direct or indirect pathways of allorecognition. For the first time, these pathways have been simultaneously compared in a cohort of 22 longstanding renal allograft recipients (13 with good function and nine with CAN). CD4+ T cells from all patients reveal donor-specific hyporesponsiveness by the direct pathway according to proliferation or the secretion of the cytokines IL-2, IL-5, and IFN-γ. Donor-specific cytotoxic T cell responses were also attenuated. In contrast, the frequencies of indirectly alloreactive cells were maintained, patients with CAN having significantly higher frequencies of CD4+ T cells indirectly activated by allogeneic peptides when compared with controls with good allograft function. An extensive search for alloantibodies has revealed significant titers in only a minority of patients, both with and without CAN. In summary, this study demonstrates widespread donor-specific hyporesponsiveness in directly activated CD4+ T cells derived from longstanding recipients of renal allografts, whether they have CAN or not. However, patients with CAN have significantly higher frequencies of CD4+ T cells activated by donor Ags in an indirect manner, a phenomenon resembling split tolerance. These findings provide an insight into the pathogenesis of CAN and also have implications for the development of a clinical tolerance assay.
机译:慢性同种异体肾病(CAN)是晚期肾同种异体移植失败的主要原因。这个复杂的过程是多因素起源的,并且有充分的证据证明免疫介导的作用。对这一过程的免疫贡献是由CD4 + T细胞控制的,它可以通过同种异体认知的直接或间接途径激活。首次在22位长期接受同种异体肾移植的患者中同时比较了这些途径(13位具有良好功能,而9位具有CAN)。来自所有患者的CD4 + T细胞根据细胞因子IL-2,IL-5和IFN-γ的增殖或分泌,通过直接途径显示供体特异性低反应性。供体特异性的细胞毒性T细胞反应也减弱了。相反,与同种异体移植功能良好的对照组相比,间接同种异体反应细胞的频率得以维持,CAN患者的同种异体肽间接激活的CD4 + T细胞的频率明显更高。对同种抗体的广泛研究表明,无论有无CAN,只有少数患者具有显着的滴度。总而言之,这项研究证明了直接激活的CD4 + T细胞中广泛存在的供体特异性低反应性,这些细胞源自长期接受肾移植的受体,无论他们是否患有CAN。但是,CAN患者通过供体Ags间接激活的CD4 + T细胞的频率明显更高,这种现象类似于分裂耐受。这些发现提供了对CAN发病机制的洞察力,也对临床耐受性测定的发展有启示。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号